Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
4.130
+0.120 (2.99%)
At close: Sep 29, 2026, 4:00 PM EDT
4.200
+0.070 (1.69%)
After-hours: Sep 29, 2026, 7:30 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $782.96 million as of September 29, 2026. Its market cap has increased by 111.43% in one year.
Market Cap
782.96M
Enterprise Value
598.37M
1-Year Change
111.43%
Ranking
Category
Stock Price
$4.13
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $782.96M, an increase of 22.43%. That is a compound annual growth rate of 3.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 782.96M | 4.64% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 804.36M |
| Geron | 803.09M |
| Aclaris Therapeutics | 799.29M |
| Achieve Life Sciences | 797.49M |
| Gyre Therapeutics | 794.19M |
| Inventiva | 793.87M |
| Solid Biosciences | 780.60M |
| Design Therapeutics | 773.51M |